NCT02767102

Brief Summary

Melatonin (MLT) is a bioactive compound in red wine. The investigators will investigate the serum and salivary concentrations and antioxidant power of MLT after the intake of a glass of red wine. Twelve healthy volunteers were recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1) and without MLT (placebo), via a randomized, cross-over, and double-blind design. Serum and salivary MLT will be measured by liquid chromatography coupled to mass spectrometry (LC-MS) and enzyme-linked immunosorbent (ELISA), respectively. The ferric ion reducing antioxidant power (FRAP) will be analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 10, 2016

Completed
Last Updated

May 10, 2016

Status Verified

May 1, 2016

Enrollment Period

8 months

First QC Date

April 30, 2016

Last Update Submit

May 5, 2016

Conditions

Keywords

Mediterranean dietindoleaminenutraceuticalsnutritionoxidative stress

Outcome Measures

Primary Outcomes (1)

  • Serum and salivary melatonin after red wine intake (with or without MLT)

    LC-MS analyses for serum and ELISA analyses for saliva

    Time-course of the serum melatonin levels in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary melatonin levels in healthy volunteer from 0 min to 120 min after administration of red wine.

Secondary Outcomes (1)

  • Antioxidant power of saliva and serum after red wine intake (with or without MLT)

    Time-course of the serum antioxidant power in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary antioxidant power in healthy volunteer from 0 min to 120 min after administration of red wine.

Other Outcomes (1)

  • Adverse effects

    Acute side effects during the trial recorded at each experimental day each experimental day, up to 1 day after

Study Arms (2)

Red wine with Melatonin

EXPERIMENTAL

Rosso di Marco is a wine without MLT (previous screening). This wine will be enriched with 10 ng mL-1 MLT (MLT+) and used as experimental wine.

Other: Red wine with melatonin

Red wine without Melatonin

PLACEBO COMPARATOR

Rosso di Marco is a wine without MLT (previous screening). This wine will be used as placebo treatment (PLC).

Other: Red wine without melatonin

Interventions

Twelve healthy volunteers will be recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1)

Red wine with Melatonin

Twelve healthy volunteers will be recruited to receive both 125 mL of red wine without MLT

Red wine without Melatonin

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to be healthy
  • to have normal weight (BMI 18.5-25.0)
  • to voluntarily accept to participate to the study.

You may not qualify if:

  • pregnancy and lactation for women;
  • supplementation with MLT and/or any other dietary supplement (vitamins, antioxidants, botanicals, phytochemicals)
  • systemic and chronic-degenerative diseases
  • abnormal hematological parameters
  • heavy smoking and alcohol drinking
  • high-intensity physical activity
  • under pharmacological treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Milan

Milan, Italy, 20142, Italy

Location

MeSH Terms

Interventions

Melatonin

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 30, 2016

First Posted

May 10, 2016

Study Start

July 1, 2014

Primary Completion

March 1, 2015

Study Completion

July 1, 2015

Last Updated

May 10, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations